Research project FEMTURA
This project aims to develop FEMTURA, a new biomaterial that makes it possible to use a patient’s own fat tissue for full breast reconstruction after mastectomy. By enabling safe transplantation of larger volumes of fat, FEMTURA could reduce the need for repeated surgical procedures and improve recovery and quality of life for breast cancer patients. The project combines biomedical engineering research with product development to improve the effectiveness and reliability of fat grafting. Ultimately, this innovation contributes to less invasive and more patient-friendly breast reconstruction treatments.
EU project: The Femtura project is supported within the OPZuid 2021–2027 programme, which focuses on strengthening research and innovation capacity and supporting the deployment of advanced technologies.
About the project FEMTURA
FEMTURA is a project focused on the development of an innovative biomaterial that enables, for the first time, large‑volume fat grafting for complete breast reconstruction following mastectomy in breast cancer patients. The objective of the project is to improve the safety and effectiveness of fat grafting procedures, thereby reducing the need for multiple surgical interventions and supporting patient recovery.
Within the project, VivArt‑X B.V. is responsible for the technical design and product development of FEMTURA. The Department of Biomedical Engineering at Eindhoven University of Technology (TU/e) contributes through preclinical research, performing technical studies aimed at optimizing the material’s properties. This work is carried out by a postdoctoral researcher, with additional involvement of TU/e faculty members who provide scientific expertise and guidance.
The project strengthens interregional collaboration in the Southern Netherlands and combines biomedical engineering research with industrial innovation to advance patient‑friendly solutions for breast reconstruction.
Duration: November 2025 - October 2028
Expected outcomes:
The development of Femtura will make large-volume fat grafting feasible for full breast reconstruction, reducing the number of treatment sessions and associated complications. This leads to reduced aftercare, lower psychological burden for patients, and decreased pressure on the healthcare system, while improving overall quality of life.
Key Findings: The project is currently in progress; results will be added as they become available.
Collaborative Partners:
- OPZUID, Europees programma voor transitie gedreven innovatie
- STIMULUS, Programmamanagement
- Technische Universiteit Eindhoven (TU/e)
- Maastricht University (UM)
- Maastricht University Medical Centre+ (MUMC+)
- VIVART-X
